🇺🇸 FDA
Patent

US 7605237

High affinity human antibodies to human IL-4 receptor

granted A61KA61K2039/505A61P

Quick answer

US patent 7605237 (High affinity human antibodies to human IL-4 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61P, A61P11/00, A61P11/06